Selected Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2017

Selected Quarterly Financial Information (Unaudited)

Schedule of unaudited consolidated financial results of operations

(amounts in thousands, except per share data)	March 31			June 30			September 30			December 31
2017 Quarter Ended
Revenues	$	1,678		$	1,051		$	1,468		$	1,122
Operating expenses		(16,878	)		(16,613	)		(22,193	)		(23,403	)
Loss from operations		(15,200	)		(15,562	)		(20,725	)		(22,281	)
Other income (expense)		326			(7	)		328			120
Income tax (expense) benefit		(349	)		967			(1,872	)		(101	)
Net loss		(15,223	)		(14,602	)		(22,269	)		(22,262	)
Basic and diluted loss per share(1)	$	(0.56	)	$	(0.54	)	$	(0.79	)	$	(0.61	)
2016 Quarter Ended
Revenues	$	1,419		$	1,785		$	971		$	2,307
Operating expenses		(16,121	)		(13,311	)		(15,050	)		(17,047	)
Loss from operations		(14,702	)		(11,526	)		(14,079	)		(14,740	)
Other income (expense)		1,086			(590	)		107			(1,118	)
Income tax (expense) benefit		17			12			(28	)		671
Net loss		(13,599	)		(12,104	)		(14,000	)		(15,187	)
Basic and diluted loss per share(1)	$	(0.64	)	$	(0.57	)	$	(0.66	)	$	(0.68	)

(1)   Net loss per share amounts may not agree to the per share amounts for the full year due to the use of weighted average shares for each period. Additionally, loss per share for the quarter ended March 31, 2017 and all the quarters in 2016 are recast to reflect the Redomicilation Transaction, accordingly the loss per share presented is based on the equivalent number of Nabriva Ireland ordinary shares outstanding in all periods.